Screening for Fabry Disease in Male Patients With Arrhythmia Requiring a Pacemaker or an Implantable Cardioverter-Defibrillator

Circulation. 2021 Feb 23;143(8):872-874. doi: 10.1161/CIRCULATIONAHA.120.051400. Epub 2021 Feb 22.

¹ Departments of Neurology (D.H.), Ghent University Hospital, Belgium.
² UD-PrOZA - Program for Undiagnosed Rare Diseases (D.H., B.P., W.T.), Ghent University Hospital, Belgium.
³ Departments of Cardiology (J.D.K.), Jan Yperman Hospital, Ypres, Belgium.
⁴ Cardiology (F.V.H.), Ghent University Hospital, Belgium.
⁵ Department of Cardiovascular Sciences, University of Leuven, Belgium (R.W.).
⁶ Department of Cardiology, AZ Sint-Lucas, Ghent, Belgium (H.V.).
⁷ Department of Cardiology, Cliniques Universitaires de Bruxelles Hôpital Erasme and Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Brussels, Belgium (A.B.).
⁸ Department of Cardiology, Brussels University Hospital, Belgium (C.d.A.).
⁹ Department of Cardiology, Antwerp University Hospital, Belgium (J.S.).
¹⁰ Department of Cardiology, AZ Delta, Roeselare, Belgium (S.V.d.W.).
¹¹ Department of Cardiology, Centre Hospitalier Universitaire Ambroise Paré, Mons, Belgium (P.G.).
¹² Department of Cardiology and Inherited Cardiomyopathies, Clinic for Pediatric and Adolescent Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Germany (C.K.).
¹³ Clinical Biology (H.S.), Ghent University Hospital, Belgium.
¹⁴ Center for Medical Genetics (B.P.), Ghent University Hospital, Belgium.
¹⁵ General Internal Medicine and Nephrology (W.T.), Jan Yperman Hospital, Ypres, Belgium.

No abstract available

Keywords: Fabry disease; arrhythmias, cardiac; diagnostic screening programs.

Publication types